BioTime Sets Up OrthoCyte Subsidiary for Stem Cell Based Orthopedic Products
BioTime has set up a subsidiary OrthoCyte to focus on the development of novel stem cell-based regenerative products for orthopedics. Potential products will include therapeutics for bone, cartilage, tendons, and …
[Read the full article here]Related News:
BioTime forms new subsidiary, OrthoCyte, to develop new therapeutic based stem cell technology
BioTime Sets Up Subsidiary in China to Develop Stem Cell Therapeutics
BioTime to form Asian subsidiary for stem cell products